pharma · Congenital Adrenal Hyperplasia · Carcinoid Syndrome · CRNX
Crinetics Pharmaceuticals Europe
Crinetics Pharmaceuticals Europe GmbH
Crinetics Pharmaceuticals Europe trial registry — 19 ClinicalTrials.gov studies with program phase, status, and indication context.
6055 Lusk Blvd, San Diego, California 92121, US HQ
2008 Founded
597 Employees
Public company Type
CRNX · NYSE Ticker
Company details
- Status
- Public
- HQ
- 6055 Lusk Blvd, San Diego, California 92121, US
- Founded
- 2008
- Employees
- 597
- Programs
- 12
- Drugs
- 4
- Patents
- 26
Crinetics Pharmaceuticals Europe clinical trials
Registry index of 19 ClinicalTrials.gov studies linked to Crinetics Pharmaceuticals Europe programs — each row shows trial ID, program name, phase, status, and indication.
Crinetics Pharmaceuticals Europe trial registry — 19 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Crinetics Pharmaceuticals Europe.
-
Paltusotine — Phase 3
Clinical update -
Paltusotine — Phase 3
Clinical update -
Randomized: 40 mg Paltusotine — Phase 2
Clinical update -
CRN09682 — Phase 2
Clinical update -
CRN04894 Oral Solution — Phase 1
Clinical update -
CRN01941 Oral Solution — Phase 1
Clinical update -
Atumelnant — Phase 3
Clinical update -
atumelnant — Phase 2
Clinical update